Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

DexCare

Explore full profile

A PaaS for health systems that intelligently orchestrates digital demand and health system capacity across all lines of care

Seattle, United StatesFounded 2021Health Tech & Medtech
Valuation $250–500M Last recorded · 2023
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for DexCare and the history behind them.

About DexCare

DexCare is a technology startup that operates in the healthcare sector, specifically focusing on improving patient care discovery solutions. The company's primary objective is to streamline the process of matching patients with the right healthcare providers at the right time. By doing so, DexCare aims to reduce patient wait times, improve the efficiency of clinical expertise application, and enhance the overall patient-clinician experience.

DexCare partners with health systems to facilitate this process. The company's innovative platform is used by health systems across the U.S to ensure patients discover care faster and more efficiently. The platform's functionality includes flexibly matching patient access across care settings and creating superior patient-clinician experiences.

The company's business model is based on providing its platform to health systems. It generates revenue by charging these health systems for using its platform. The platform has proven to be effective, with case studies showing that it has helped increase net new patient acquisition by 30%.

DexCare is a mission-driven company that values diversity, equity, and inclusion. It is a well-funded, mid-stage startup with a unique and flexible work culture. The company believes in remote work, giving its employees the freedom to choose where, when, and how they work.

Source: Dealroom company data

At a glance

Founded
2021
Headquarters
Seattle, United States
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Define Ventures
  • SpringRock Ventures
  • Providence Ventures
  • Kaiser Permanente Ventures
  • Frist Cressey Ventures
  • Transformation Capital

Series B and later4 investors entered at this stage

  • ICONIQ Growth
  • Community Health Network
  • Texas Health Resources
  • Tampa General Hospital
Employees mapped 138 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 21 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States96.6%
🇧🇷 Brazil2.6%
🇳🇿 New Zealand0.8%
3 countries shown
Web traffic by country
4.7K monthly visits
across markets
🇺🇸 United States89.4%
🇮🇳 India10.6%
Top 2 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about DexCare on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DexCare on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.